Multinationals are likely to leave Korea

Korea will face an exodus of foreign-invested pharmaceutical firms operating here, as many are complaining about the government’s unilateral assessment of conventional medicines and price cut, causing a sharp drop in their revenues.

Multinational drug manufacturers have called for the government to revamp the so-called positive list system to allow only cost-effective drugs to be covered by ...